Paloma Cejas

9.2k total citations · 1 hit paper
72 papers, 4.5k citations indexed

About

Paloma Cejas is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paloma Cejas has authored 72 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paloma Cejas's work include Colorectal Cancer Treatments and Studies (14 papers), Epigenetics and DNA Methylation (12 papers) and Genetic factors in colorectal cancer (12 papers). Paloma Cejas is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Epigenetics and DNA Methylation (12 papers) and Genetic factors in colorectal cancer (12 papers). Paloma Cejas collaborates with scholars based in Spain, United States and Canada. Paloma Cejas's co-authors include Cristóbal Belda-Iniesta, Manuel González-Barón, Javier de Castro, Juan Ángel Fresno Vara, E. Casado, Jaime Feliú, Henry W. Long, Enrique Casado, Juan Moreno‐Rubio and Manuel Nistal and has published in prestigious journals such as Cell, Nature Communications and Nature Genetics.

In The Last Decade

Paloma Cejas

71 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PI3K/Akt signalling pathway and cancer

2003 1.9k citations E. Casado, Javier de Castro et al. profile →

Peers

Countries citing papers authored by Paloma Cejas

Since Specialization

Citations

This map shows the geographic impact of Paloma Cejas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paloma Cejas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paloma Cejas more than expected).

Fields of papers citing papers by Paloma Cejas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paloma Cejas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paloma Cejas. The network helps show where Paloma Cejas may publish in the future.

Co-authorship network of co-authors of Paloma Cejas

This figure shows the co-authorship network connecting the top 25 collaborators of Paloma Cejas. A scholar is included among the top collaborators of Paloma Cejas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paloma Cejas. Paloma Cejas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression 2025 ·Cancer Research ·(unknown), Kristine M. Wadosky, Neha Jaiswal, Xueji Zhang, (unknown), Prashant K. Singh, (unknown), Eduardo Cortes Gomez, Jianmin Wang, (unknown), Mark D. Long, Paloma Cejas, Shweta Kukreja, Henry W. Long, David W. Goodrich	0
2	Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer 2025 ·Cancer Discovery ·Nitin H. Shirole, (unknown), Yenarae Lee, Amy Goodale, Sudeepa Syamala, Shweta Kukreja, Rong Li, Xintao Qiu, Wenyu Yu, Seth Goldman, Paloma Cejas, Henry W. Long, Karen Adelman, John G. Doench, William R. Sellers, William G. Kaelin	2
3	Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3 2024 ·Nature Cell Biology ·Marco Seehawer, Zheqi Li, Jun Nishida, Pierre Foidart, (unknown), (unknown), Marie-Anne Goyette, Pengze Yan, (unknown), (unknown), Paloma Cejas, Henry W. Long, Malvina Papanastasiou, Kornélia Polyák	21
4	The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma 2023 ·Biomedicines ·Victoria Heredia-Soto, (unknown), Ismael Ghanem, Laura Guerra, (unknown), (unknown), Lucía Trilla‐Fuertes, Maria J. de Miguel, Paloma Cejas, (unknown), (unknown), D. Viñal, Marta Mendiola, Jaime Feliú	5
5	Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis 2022 ·British Journal of Cancer ·Joep J. de Jong, Begoña P. Valderrama, Júlia Perera‐Bel, Núria Juanpere, Paloma Cejas, Henry W. Long, M. Mar Albà, Ewan A. Gibb, Joaquim Bellmunt	13
6	High-Resolution ATAC-Seq Analysis of Frozen Clinical Tissues 2022 ·Methods in molecular biology ·Paloma Cejas, Henry W. Long	2
7	Hybrid Stomach-Intestinal Chromatin States Underlie Human Barrett’s Metaplasia 2021 ·Gastroenterology ·Harshabad Singh, (unknown), Jason L. Hornick, Shariq Madha, Paloma Cejas, Kunal Jajoo, Pratik Singh, Paz Polak, Hwajin Lee, Ramesh A. Shivdasani	23
8	ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer 2020 ·Cancer Research ·Neel Shah, Nikolas Kesten, Alba Font‐Tello, (unknown), Raga Vadhi, Klothilda Lim, Mark R. Flory, Paloma Cejas, Hisham Mohammed, Henry W. Long, Myles Brown	11
9	Universal NicE-seq for high-resolution accessible chromatin profiling for formaldehyde-fixed and FFPE tissues 2020 ·Clinical Epigenetics ·Hang Gyeong Chin, Zhiyi Sun, (unknown), (unknown), Paloma Cejas, George Spracklin, Pierre‐Olivier Estève, Shuang-yong Xu, Henry W. Long, Sriharsa Pradhan	15
10	Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells 2020 ·The Journal of Experimental Medicine ·Rong En Tay, Olamide Olawoyin, Paloma Cejas, Yingtian Xie, Clifford A. Meyer, Yoshinaga Ito, Qing Yu Weng, David E. Fisher, Henry W. Long, Myles Brown, Hye‐Jung Kim, Kai W. Wucherpfennig	46
11	Chromatin accessibility promotes hematopoietic and leukemia stem cell activity 2020 ·Nature Communications ·Lucía Cabal‐Hierro, Peter van Galen, Miguel A. Prado, (unknown), Katsuhiro Togami, Cody T. Mowery, João A. Paulo, Yingtian Xie, Paloma Cejas, Takashi Furusawa, Michael Bustin, Henry W. Long, David B. Sykes, Steven P. Gygi, Daniel Finley, B Bernstein, Andrew A. Lane	39
12	Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype 2016 ·Cancer Research ·Paloma Cejas, Alessia Cavazza, (unknown), Vı́ctor Moreno, David Horst, Juan Moreno‐Rubio, Emilio Burgos, Marta Mendiola, Len Taing, Ajay Goel, Jaime Feliú, Ramesh A. Shivdasani	19
13	The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis 2015 ·Nature Genetics ·Mark M. Pomerantz, Fugen Li, David Y. Takeda, Romina Lenci, Apurva Chonkar, Matthew Chabot, Paloma Cejas, Francisca Vázquez, Jennifer Cook, Ramesh A. Shivdasani, Michaela Bowden, Rosina T. Lis, William C. Hahn, Philip W. Kantoff, Myles Brown, Massimo Loda, Henry W. Long, Matthew L. Freedman	266
14	Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant Chemotherapy 2014 ·Molecular Cancer Therapeutics ·Ana Custodio, Juan Moreno‐Rubio, Jorge Aparicio, Javier Gállego, Ricardo Yayá, Joan Maurel, Nuria Rodrı́guez-Salas, Emilio Burgos, David Ramos, Ana Calatrava, (unknown), (unknown), (unknown), Rosário Madero, Paloma Cejas, Jaime Feliú	10
15	Genes associated with metabolic syndrome predict disease‐free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer 2014 ·Molecular Oncology ·Teodoro Vargas, Juan Moreno‐Rubio, Jesús Herránz, Paloma Cejas, Susana Molina, Margarita González‐Vallinas, Ricardo Ramos, Emilio Burgos, Cristina Aguayo, Ana Custodio, Guillermo Reglero, Jaime Feliú, Ana Ramı́rez de Molina	26
16	A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer 2011 ·Clinical Cancer Research ·E. Casado, Víctor Moreno, José Javier Sánchez, Montserrat Blanco, Joan Maurel, Jaime Feliú, Carlos Fernández-Martos, Javier de Castro, Beatriz Castelo, Cristóbal Belda-Iniesta, María Sereno, (unknown), Emilio Burgos, Miguel Ángel García‐Cabezas, Noemí Manceñido, Rosa Miquel, Damián García‐Olmo, Manuel González-Barón, Paloma Cejas	25
17	KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis 2009 ·PLoS ONE ·Paloma Cejas, Miriam López-Gómez, Cristina Aguayo, Rosário Madero, Javier de Castro, Cristóbal Belda-Iniesta, Jorge Barriuso, Víctor Moreno, J Larrauri, Rocío López, Enrique Casado, Manuel González-Barón, Jaime Feliú	127
18	Immunohistochemical expression of p53, Bcl-2, COX-2, C-erb-B2, EPO-R, beta-catenin, and E-cadherin in non tumoral gastric mucous membrane. 2007 ·PubMed ·María Sereno, Miguel Ángel García‐Cabezas, Javier de Castro, Paloma Cejas, (unknown), Cristóbal Belda-Iniesta, (unknown), J Larrauri, Manuel Nistal, Manuel González Barón	5
19	A Critical Role for Rac1 in Tumor Progression of Human Colorectal Adenocarcinoma Cells 2007 ·American Journal Of Pathology ·Carolina Espina, María Virtudes Céspedes, Miguel Ángel García‐Cabezas, (unknown), (unknown), (unknown), Paloma Cejas, Manuel Nistal, Ramón Mangues, Juan Carlos Lacal	51
20	Molecular markers in colorectal cancer: genetic bases for a customised treatment 2007 ·Clinical & Translational Oncology ·Enrique Casado, Javier de Castro, Cristóbal Belda-Iniesta, Paloma Cejas, Jaime Feliú, María Sereno, Manuel González-Barón	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact